📰 Aktx News
Page 3 - Aktx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aktx. Real-time updates on events, politics, business and more.
July 19, 2023
By Ben Glickman Akari Therapeutics said Wednesday it has named Wendy DiCicco interim chief financial officer. The London-based biotechnology company said...
July 6, 2023
By Ben Glickman Shares of Akari Therapeutics rose Thursday after the company said it had received a positive opinion on a drug treatment's application for...
June 29, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ:AKTX opened at $0.16 on Friday. The stock has a 50-day simple moving average of $0.18 and a two-hundred day simple […]
June 5, 2023
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 0.6 % Shares of NASDAQ:AKTX opened at $0.16 on Thursday. Akari Therapeutics has a 12-month low of $0.14 and […]
June 4, 2023
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report released on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance AKTX opened at $0.16 on Thursday. Akari Therapeutics has a 1-year low of $0.14 and a 1-year high of $1.61. The stock […]
May 20, 2023
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report issued on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance NASDAQ AKTX opened at $0.21 on Tuesday. Akari Therapeutics has a 52 week low of $0.14 and a 52 week high of […]
May 19, 2023
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report sent to investors on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Akari Therapeutics stock opened at $0.21 on Tuesday. The company has a 50 day moving average price of $0.21 […]
May 13, 2023
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Rating) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 111,800 shares, a decline of 62.3% from the April 15th total of 296,900 shares. Based on an average daily volume of 444,700 shares, the days-to-cover ratio is […]
May 11, 2023
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report published on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of AKTX opened at $0.18 on Monday. The firm has a market cap of $13.10 million, a P/E ratio of -0.50 […]
May 4, 2023
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research note released on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of NASDAQ:AKTX opened at $0.18 on Friday. The company has a market capitalization of $13.40 million, a PE ratio of […]